Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial

BERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche said on Saturday its experimental multiple sclerosis drug ...
The American Journal of Managed Care

Role of Antibody-Drug Conjugates in Multiple Myeloma

Explore the latest advancements in bispecific antibodies for multiple myeloma, focusing on early treatment opportunities and innovative trial designs.
Hosted on MSN

New potential drug targets for multiple sclerosis identified

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...
Fierce Pharma

J&J sharpens Darzalex's edge with quadruplet FDA nod in newly diagnosed multiple myeloma

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...
Managed Healthcare Executive

FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.